TrialSignal
Clinical trial intelligence report
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT02477202
Status
COMPLETED
Phase
NA
Sponsor
Memorial Sloan Kettering Cancer Center
Executive brief
Investment-Ready Snapshot
This study evaluates the effect of the Mirena® IUD on cell proliferation in the fallopian tube fimbriae, which may serve as a biomarker for reduced risk of invasive epithelial ovarian cancer (IEOC) in women aged 35-50 undergoing risk-reducing surgeries.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02477202
Indication
Epithelial Ovarian Cancer
Modality
medical device
Target
Epithelial Ovarian Cancer
Intervention
Mirena® intra-uterine device (IUD)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.